UM

Browse/Search Results:  1-3 of 3 Help

Selected(0)Clear Items/Page:    Sort:
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside Review article
2024
Authors:  Bao, Xuhui;  Liang, Yongjun;  Chang, Hanman;  Cai, Tianji;  Feng, Baijie; et al.
Favorite | TC[WOS]:19 TC[Scopus]:18  IF:40.8/40.5 | Submit date:2024/05/16
Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside Journal article
Bao, Xuhui, Yongjun Liang, Hanman Chang, CAI TIANJI, Baijie Feng, Konstantin Gordon, Yuekun Zhu, Hailian Shi, Yundong He, Liyi Xie. Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside[J]. Signal Transduction and Targeted Therapy, 2024, 9(13).
Authors:  Bao, Xuhui;  Yongjun Liang;  Hanman Chang;  CAI TIANJI;  Baijie Feng; et al.
Favorite | TC[Scopus]:11  IF:40.8/40.5 | Submit date:2024/08/02
Elevated Risk of Radiation Therapy–Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA Breast Cancer Journal article
Xie, Liyi, Bao, Xuhui, Cai, Tianji, Silva, Susan G., Ma, Jinli, Zhang, Zhen, Guo, Xiaomao, Marks, Lawrence B.. Elevated Risk of Radiation Therapy–Associated Second Malignant Neoplasms in Young African-American Women Survivors of Stage I-IIIA Breast Cancer[J]. International Journal of Radiation Oncology Biology Physics, 2019, 105(2), 275-284.
Authors:  Xie, Liyi;  Bao, Xuhui;  Cai, Tianji;  Silva, Susan G.;  Ma, Jinli; et al.
Favorite | TC[WOS]:3 TC[Scopus]:3  IF:6.4/6.1 | Submit date:2022/05/17